Amylyx Pharmaceuticals, Inc.
AMLX
Kedudukan dalam Saham
#4271
Amylyx Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical... Amylyx Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm, primarily focused on creating therapies for amyotrophic lateral sclerosis (ALS) and various other neurodegenerative conditions. A key asset in its developmental pipeline is AMX0035, a proprietary dual UPR-Bax apoptosis inhibitor. This compound, which integrates sodium phenylbutyrate and taurursodiol, is under investigation for treating ALS, and its application is also being explored for other neurodegenerative diseases. The company was established in 2013 and is based in Cambridge, Massachusetts.
Harga Saham
$29.32
Disegerakkan terakhir: 2026-10-21
Modal Pasaran
$3.68B
Perubahan (1 hari)
1.91%
Perubahan (1 tahun)
97.84%
Negara
US
Perdagangan Amylyx Pharmaceuticals, Inc. (AMLX)
Kategori
Healthcare
Sejarah harga saham bagi Amylyx Pharmaceuticals, Inc. (AMLX)
Harga penutupan tertinggi: $27.68 pada 2026-10-01
Harga penutupan terendah: $19.75 pada 2022-01-01
Harga penutupan terendah: $19.75 pada 2022-01-01
Sejarah harga saham Amylyx Pharmaceuticals, Inc. dari 2022 hingga 2026
Prestasi harga saham tahunan
| Tahun | Prestasi |
|---|---|
| 2026 (TTM) | 41.29% |
| 2025 | 192.53% |
| 2024 | -69.40% |
| 2023 | -60.37% |
| 2022 | 0.00% |
Harga saham bagi syarikat atau pesaing serupa
| Syarikat | Harga saham | Perubahan 1thn% | Negara |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.06 | -4.32% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
